Swiss National Bank
TARO

Swiss National Bank’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Swiss National Bank’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-18,600
Closed -$788K – 2528
2024
Q1 		$788K Hold
18,600
– – ﹤0.01% 2331
2023
Q4 		$777K Sell
18,600
-2,300
-11% -$84.8K ﹤0.01% 2367
2023
Q3 		$788K Hold
20,900
– – ﹤0.01% 2370
2023
Q2 		$793K Buy
20,900
+400
+2% +$12.6K ﹤0.01% 2411
2023
Q1 		$499K Sell
20,500
-2,000
-9% -$58.3K ﹤0.01% 2521
2022
Q4 		$653K Hold
22,500
– – ﹤0.01% 2508
2022
Q3 		$675K Hold
22,500
– – ﹤0.01% 2478
2022
Q2 		$814K Buy
22,500
+200
+0.9% +$7.63K ﹤0.01% 2468
2022
Q1 		$965K Buy
22,300
+1,400
+7% +$65.4K ﹤0.01% 2424
2021
Q4 		$1.05M Sell
20,900
-300
-1% -$16.8K ﹤0.01% 2454
2021
Q3 		$1.35M Hold
21,200
– – ﹤0.01% 2284
2021
Q2 		$1.53M Sell
21,200
-600
-3% -$44.1K ﹤0.01% 2268
2021
Q1 		$1.61M Hold
21,800
– – ﹤0.01% 2135
2020
Q4 		$1.6M Buy
+21,800
New +$1.4M ﹤0.01% 2035
2017
Q4 		– Sell
-47,100
Closed -$5.31M – 2538
2017
Q3 		$5.31M Buy
47,100
+600
+1% +$65.3K 0.01% 981
2017
Q2 		$5.21M Sell
46,500
-6,700
-13% -$757K 0.01% 968
2017
Q1 		$6.2M Sell
53,200
-3,800
-7% -$421K 0.01% 861
2016
Q4 		$6M Sell
57,000
-70,200
-55% -$7.35M 0.01% 850
2016
Q3 		$14.1M Sell
127,200
-1,700
-1% -$225K 0.02% 585
2016
Q2 		$18.8M Buy
128,900
+97,700
+313% +$13.9M 0.03% 530
2016
Q1 		$4.28M Buy
31,200
+1,700
+6% +$241K 0.01% 965
2015
Q4 		$4.56M Buy
+29,500
New +$4.31M 0.01% 831

Other funds holding TARO

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
LI
LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return
GCM
Gladius Capital Management Chicago, Illinois $1.65B AUM 25.75% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Swiss National Bank's TARO Position: Q2 2024 in Review

Swiss National Bank sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2024, closing a stake of 18,600 shares — an estimated $788K sold.

Swiss National Bank first reported a position in TARO in Q4 2015 and held it in 22 quarters. The position peaked at $18.8M in Q2 2016. 16 funds tracked by Wall St. Rank hold TARO as of Q2 2024.

  • Swiss National Bank reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2024 after selling out during the quarter.
  • Swiss National Bank sold 18,600 Taro Pharmaceutical Industries Ltd. shares in Q2 2024, an estimated $788K.
  • Swiss National Bank first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2015 and held it in 22 quarters.
  • Swiss National Bank's Taro Pharmaceutical Industries Ltd. position peaked at $18.8M in Q2 2016.
  • 16 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2024.

Based on Swiss National Bank's 13F filing for Q2 2024, filed 8 Aug 2024.